Literature DB >> 22239762

Investigation of confined placental mosaicism by CGH in IVF and ICSI pregnancies.

E Chan Wong1, C Hatakeyama, A Minor, S Ma.   

Abstract

BACKGROUND: Assisted reproductive technologies include in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). It has been shown that embryos derived from ART have higher rates of aneuploidy. Although the majority of ART pregnancies are genetically normal, it is suspected that aneuploid embryos may persist as mosaics and lead to confined placental mosaicism (CPM). Due to the greater risks of sperm aneuploidy in infertile men, CPM may be more prevalent in ICSI than IVF pregnancies. In this report, we investigated the prevalence of CPM in IVF and ICSI pregnancies using comparative genomic hybridization and flow cytometry.
METHODS: The placenta and umbilical cord blood were collected after birth. To determine the presence of CPM, karyotypes of umbilical cord blood were compared to the results of placental analyses. For each placenta, multiple villous sites were investigated for DNA gains/losses and polyploidy using comparative genomic hybridization and flow cytometry. Detected abnormalities were further confirmed by fluorescent in-situ hybridization (FISH).
RESULTS: In total, 134 IVF/ICSI cases were investigated. CPM was detected in five of these cases (5/134) giving an overall rate of 3.73%. CPM was detected in one IVF case (1/31; 3.23%) and four ICSI cases (4/103; 3.88%). The prevalence of CPM in IVF and ICSI pregnancies was not statistically different from each other. CPM was not observed in 13 ICSI and 6 IVF cases that were determined to be small for gestational age (SGA).
CONCLUSIONS: The prevalence of CPM in ICSI pregnancies is not greater than IVF pregnancies. In addition, the overall prevalence of CPM in ART pregnancies (IVF and ICSI) is similar to that of the general population. CPM was not observed in the limited cases that were affected by small for gestational age. Our results suggest that ART pregnancies are not at a greater risk for CPM.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22239762     DOI: 10.1016/j.placenta.2011.11.024

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  2 in total

1.  Maternal origin of 47,XXY and confined placental mosaicism 47,XXY/48,XXY,+13 in an infant conceived through IVF.

Authors:  Elizabeth X Wu; Andrew D Wilson; Edgar Chan Wong; Jon C Havelock; Sai Ma
Journal:  J Assist Reprod Genet       Date:  2013-04-27       Impact factor: 3.412

2.  Placental mosaicism for Trisomy 13: a challenge in providing the cell-free fetal DNA testing.

Authors:  Xiang-Yin Liu; Hong-Guo Zhang; Rui-Xue Wang; Shuang Chen; Xiao-Wei Yu; Rui-Zhi Liu
Journal:  J Assist Reprod Genet       Date:  2014-02-05       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.